L’Oréal has made its first open innovation investment in China by acquiring a minority stake in SHINEHIGH INNOVATION, a biotech start-up known for its work in supramolecular chemistry. The deal was made through Meicifang, L’Oréal’s local venture capital arm, and marks a strategic step in the company’s push for advanced cosmetic technologies.
This investment is part of L’Oréal’s global BOLD (Business Opportunities for L’Oréal Development) initiative and follows the BIG BANG Beauty Tech Innovation Challenge, which has supported partnerships in China over the past four years. SHINEHIGH, founded in 2017 by Professor Jiaheng Zhang, has developed self-assembling technology that allows active ingredients to work more effectively together. This innovation improves the performance, sustainability, and stability of skincare and haircare products.
Through this partnership, L’Oréal aims to develop next-generation solutions for skin, hair, and scalp care. By using SHINEHIGH’s technology, the company hopes to overcome common challenges in formulation, such as ingredient compatibility and delivery.
As China strengthens its position as a global center for innovation, L’Oréal’s investment signals a strong commitment to long-term collaboration and scientific advancement. By partnering with SHINEHIGH, the beauty giant is also responding to growing consumer demand for high-performance and eco-friendly products—reinforcing its role as a leader in the future of global beauty.
Related Topics:
